Robert K. Bright
Robert K. Bright
Professor of Immunology and Molecular Microbiology, Texas Tech University Health Sciences Center
Verified email at - Homepage
Cited by
Cited by
VEGF and VEGF type C play an important role in angiogenesis and lymphangiogenesis in human malignant mesothelioma tumours
Y Ohta, V Shridhar, RK Bright, GP Kalemkerian, W Du, M Carbone, ...
British journal of cancer 81 (1), 54-61, 1999
Generation and genetic characterization of immortal human prostate epithelial cell lines derived from primary cancer specimens
RK Bright, CD Vocke, MR Emmert-Buck, PH Duray, D Solomon, P Fetsch, ...
Cancer research 57 (5), 995-1002, 1997
The UV (Ribotoxic) stress response of human keratinocytes involves the unexpected uncoupling of the Ras-extracellular signal-regulated kinase signaling cascade from the …
MS Iordanov, RJ Choi, OP Ryabinina, TH Dinh, RK Bright, BE Magun
Molecular and cellular biology 22 (15), 5380-5394, 2002
Differential regulation of matrix metalloproteinase‐9, tissue inhibitor of metalloproteinase‐1 (TIMP‐1) and TIMP‐2 expression in co‐cultures of prostate cancer and stromal cells
Z Dong, JA Nemeth, ML Cher, KC Palmer, RC Bright, R Fridman
International journal of cancer 93 (4), 507-515, 2001
A bactericidal antibody to Borrelia burgdorferi is directed against a variable region of the OspB protein
A Sadziene, M Jonsson, S Bergström, RK Bright, RC Kennedy, ...
Infection and immunity 62 (5), 2037-2045, 1994
CD4+ T lymphocytes play a critical role in antibody production and tumor immunity against simian virus 40 large tumor antigen
RC Kennedy, MH Shearer, AM Watts, RK Bright
Cancer research 63 (5), 1040-1045, 2003
Induction of tumorigenesis and metastasis by the murine orthologue of tumor protein D52
JD Lewis, LA Payton, JG Whitford, JA Byrne, DI Smith, LB Yang, RK Bright
Molecular cancer research 5 (2), 133-144, 2007
Nonredundant functions for tumor protein D52-like proteins support specific targeting of TPD52
M Shehata, I Bieche, R Boutros, J Weidenhofer, S Fanayan, L Spalding, ...
Clinical Cancer Research 14 (16), 5050-5060, 2008
Protection against a lethal tumor challenge with SV40-transformed cells by the direct injection of DNA-encoding SV40 large tumor antigen
RK Bright, B Beames, MH Shearer, RC Kennedy
Cancer research 56 (5), 1126-1130, 1996
Overexpressed oncogenic tumor-self antigens: New vaccine targets
RK Bright, JD Bright, JA Byrne
Human vaccines & immunotherapeutics 10 (11), 3297-3305, 2014
Tumor protein D52 (TPD52) and cancer—oncogene understudy or understudied oncogene?
JA Byrne, S Frost, Y Chen, RK Bright
Tumor Biology 35, 7369-7382, 2014
Immunization of BALB/c mice with recombinant simian virus 40 large tumor antigen induces antibody-dependent cell-mediated cytotoxicity against simian virus 40-transformed cells …
RK Bright, MH Shearer, RC Kennedy
Journal of immunology (Baltimore, Md.: 1950) 153 (5), 2064-2071, 1994
Thrombospondin‐1 expression and clinical implications in malignant pleural mesothelioma
Y Ohta, V Shridhar, GP Kalemkerian, RK Bright, Y Watanabe, HI Pass
Cancer 85 (12), 2570-2576, 1999
Sperm protein 17 is expressed in human somatic ciliated epithelia
F Grizzi, M Chiriva-Internati, B Franceschini, K Bumm, P Colombo, ...
Journal of Histochemistry & Cytochemistry 52 (4), 549-554, 2004
Tumor-associated antigens: from discovery to immunity
JD Lewis, BD Reilly, RK Bright
International reviews of immunology 22 (2), 81-112, 2003
Differential requirement for the stress-activated protein kinase/c-Jun NH2-terminal kinase in RNA damage-induced apoptosis in primary and in immortalized fibroblasts
MS Iordanov, J Wong, DL Newton, SM Rybak, RK Bright, RA Flavell, ...
Molecular Cell Biology Research Communications 4 (2), 122-128, 2000
Gene transfer of interleukin 13 receptor α2 chain dramatically enhances the antitumor effect of IL-13 receptor–targeted cytotoxin in human prostate cancer xenografts
K Kawakami, SR Husain, RK Bright, RK Puri
Cancer Gene Therapy 8 (11), 861-868, 2001
Regulated CYP19 Aromatase Transcription in Breast Stromal Fibroblasts
RJ Pauley, SJ Santner, LR Tait, RK Bright, RJ Santen
The Journal of Clinical Endocrinology & Metabolism 85 (2), 837-846, 2000
TPD52 expression increases neutral lipid storage within cultured cells
A Kamili, N Roslan, S Frost, LC Cantrill, D Wang, A Della-Franca, ...
Journal of cell science 128 (17), 3223-3238, 2015
TPD52 represents a survival factor in ERBB2‐amplified breast cancer cells
N Roslan, I Bièche, RK Bright, R Lidereau, Y Chen, JA Byrne
Molecular Carcinogenesis 53 (10), 807-819, 2014
The system can't perform the operation now. Try again later.
Articles 1–20